19 results
Phosphate Binders - Pros and Cons

Calcium carbonate (TumsTM) 
 - Most inexpensive, antacid properties useful for
Phosphate Binders ... and metal-free binder ... edgarvlermamd - Nephrology ... #Table #Comparison ... #Pharmacology #Nephrology
Key Characteristics of Old and New Potassium-Binding Agents

- Dr. Edgar V. Lerma https://twitter.com/edgarvlermamd

#Potassium #Binding #KBinders #Kayexelate
Potassium #Binding #KBinders ... #Kayexelate #Comparison ... #Table #Pharmacology ... #HyperKalemia #Nephrology
Potassium Binders for Management of Hyperkalemia
 • SPS - Sodium polystyrene sulfonate
 • Patiromer (veltassa)
 •
Potassium Binders ... for Management ... #Management #Hyperkalemia ... #pharmacology #table ... #comparison #nephrology
Table 22 provides the characteristics of various phosphate-binding agents.
#Pharmacology #Nephrology #Phosphate #Phosphorus #Binders #Comparison #Table #Disadvantages
Table 22 provides ... #Pharmacology #Nephrology ... Phosphate #Phosphorus #Binders ... #Comparison #Table
Stroke Evaluation and Management Algorithm

Clinical suspicion of stroke (BE FAST)
 • Balance loss
 • Eyes: vision
Evaluation and Management ... Algorithm Clinical ... Immediate Workup Ischemic ... Klaas #Stroke #Management ... #differential #neurology
Characteristics of Commonly Used Phosphate Binders 
Aluminum 
 - Potent and effective 
 - Useful for
Used Phosphate Binders ... edgarvlermamd - Nephrology ... #Phosphate #Binders ... #Table #Comparison ... #Pharmacology #Nephrology
Indications for tPA in Stroke:
 • Clinical diagnosis of ischemic stroke
 • Measurable neurologic deficit
 •
in Stroke: • Clinical ... diagnosis of ischemic ... • Measurable neurologic ... #Stroke #cva #management ... #neurology
Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor
risk transient ischaemic ... attack and minor ischaemic ... stroke: a clinical ... #TIA #Stroke #Neurology ... #Management #Aspirin
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Erythematosus (SLE) Clinical ... that will cause ischemia ... cyclophosphamide • Ischemic ... Erythematosus #SLE #CNS #neurology ... cerebritis #diagnosis #management
Restarting Anticoagulation after TIA or Acute Ischemic Stroke

 • TIA → Consider (re-) starting a NOAC
after TIA or Acute Ischemic ... neurological deficit → No clinical ... worsening or clinical ... #Stroke #CVA #neurology ... #management